"Survival Analysis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A class of statistical procedures for estimating the survival function (function of time, starting with a population 100% well at a given time and providing the percentage of the population still well at later times). The survival analysis is then used for making inferences about the effects of treatments, prognostic factors, exposures, and other covariates on the function.
Descriptor ID |
D016019
|
MeSH Number(s) |
E05.318.740.998 N05.715.360.750.795 N06.850.520.830.998
|
Concept/Terms |
Survival Analysis- Survival Analysis
- Analysis, Survival
- Analyses, Survival
- Survival Analyses
|
Below are MeSH descriptors whose meaning is more general than "Survival Analysis".
Below are MeSH descriptors whose meaning is more specific than "Survival Analysis".
This graph shows the total number of publications written about "Survival Analysis" by people in this website by year, and whether "Survival Analysis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 0 | 6 | 6 |
1995 | 0 | 5 | 5 |
1996 | 0 | 3 | 3 |
1997 | 0 | 9 | 9 |
1998 | 0 | 6 | 6 |
1999 | 0 | 8 | 8 |
2000 | 0 | 13 | 13 |
2001 | 0 | 14 | 14 |
2002 | 0 | 17 | 17 |
2003 | 1 | 23 | 24 |
2004 | 0 | 27 | 27 |
2005 | 0 | 22 | 22 |
2006 | 0 | 25 | 25 |
2007 | 1 | 24 | 25 |
2008 | 1 | 21 | 22 |
2009 | 0 | 14 | 14 |
2010 | 0 | 21 | 21 |
2011 | 0 | 15 | 15 |
2012 | 0 | 26 | 26 |
2013 | 1 | 20 | 21 |
2014 | 0 | 22 | 22 |
2015 | 1 | 35 | 36 |
2016 | 1 | 24 | 25 |
2017 | 0 | 27 | 27 |
2018 | 1 | 27 | 28 |
2019 | 1 | 18 | 19 |
2020 | 0 | 7 | 7 |
2021 | 0 | 8 | 8 |
2022 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Survival Analysis" by people in Profiles.
-
Applying mixture cure survival modeling to medication persistence analysis. Pharmacoepidemiol Drug Saf. 2022 07; 31(7):788-795.
-
Genomic predictors of response to PD-1 inhibition in children with germline DNA replication repair deficiency. Nat Med. 2022 01; 28(1):125-135.
-
Impact of kidney transplantation on functional status. Ann Med. 2021 12; 53(1):1302-1308.
-
Neoadjuvant presurgical PD-1 inhibition in oral cavity squamous cell carcinoma. Cell Rep Med. 2021 10 19; 2(10):100426.
-
Response and recurrence correlates in individuals treated with neoadjuvant anti-PD-1 therapy for resectable oral cavity squamous cell carcinoma. Cell Rep Med. 2021 10 19; 2(10):100411.
-
TNK1 is a ubiquitin-binding and 14-3-3-regulated kinase that can be targeted to block tumor growth. Nat Commun. 2021 09 09; 12(1):5337.
-
An analysis of outcomes for pediatric trauma warm fresh whole blood recipients in Iraq and Afghanistan. Transfusion. 2021 07; 61 Suppl 1:S2-S7.
-
Comparison and impact of COVID-19 for patients with cancer: a survival analysis of fatality rate controlling for age, sex and cancer type. BMJ Health Care Inform. 2021 May; 28(1).
-
Induced Torpor as a Countermeasure for Low Dose Radiation Exposure in a Zebrafish Model. Cells. 2021 04 14; 10(4).
-
The presence of an endometrioid component does not alter the clinicopathologic profile or survival of patients with uterine serous cancer: A gynecologic oncology group (GOG/NRG) study of 934 women. Gynecol Oncol. 2021 03; 160(3):660-668.